平均心肺剂量与椎体骨髓剂量差异预测食管癌放疗中谱系特异性白细胞减少动力学
本研究纳入46例接受放化疗的II-III期食管癌患者,评估每周及放疗后90天血细胞计数,从剂量体积直方图提取胸椎体积受照 spared(TVS)参数,并以心脏、肺和大血管体积总和平均剂量作为循环血池替代指标(mCPD)。多因素分析显示mCPD与较低的白细胞和中性粒细胞最低值相关(p<0.05),TVS5-40 Gy与较高的淋巴细胞最低值相关(均p<0.05);重复测量ANOVA显示性别、年龄(<67 vs. >67)和糖尿病对淋巴细胞趋势有交互效应(均p<0.015)。结论认为mCPD与胸椎骨髓受照 spared体积差异预测放化疗期间谱系特异性白细胞减少。
要点
- mCPD与较低的白细胞和中性粒细胞最低值独立相关(p<0.05)。
- TVS5-40 Gy与较高的淋巴细胞最低值相关(均p<0.05)。
- 性别、年龄和糖尿病可能影响淋巴细胞下降速度(交互效应p<0.015)。
核心结论
- mCPD和胸椎骨髓受照 spared体积差异预测食管癌放化疗期间谱系特异性白细胞减少。
- mCPD显著与较低的总白细胞和中性粒细胞最低值相关,而更大的胸椎骨髓受照 spared体积与减轻淋巴细胞减少相关。
研究设计与样本
- 研究纳入46例接受放化疗的II-III期食管癌患者,评估每周及放化疗后90天血细胞计数。
- 从剂量体积直方图提取胸椎体积受照 spared(TVS)参数,以心脏、肺和大血管体积总和平均剂量计算mCPD作为循环血池替代指标。
- 采用线性和逻辑回归识别剂量学变量与血液学毒性之间的关联,重复测量ANOVA检验细胞计数趋势与临床预测因素的关联。
主要发现
- 白细胞和血小板在放化疗第6周达到最低值。
- 多因素分析中,mCPD与较低的白细胞和中性粒细胞最低值相关(p<0.05)。
- TVS5-40 Gy与较高的淋巴细胞最低值相关(均p<0.05)。
- 重复测量ANOVA显示性别对绝对淋巴细胞趋势有交互效应,年龄(<67 vs. >67)和糖尿病对归一化淋巴细胞趋势有交互效应(均p<0.015)。
关键数值与推荐
- mCPD与较低的白细胞和中性粒细胞最低值相关(p<0.05)。
- TVS5-40 Gy与较高的淋巴细胞最低值相关(均p<0.05)。
- 性别、年龄(<67 vs. >67)和糖尿病对淋巴细胞趋势的交互效应均p<0.015。
临床怎么用
- 放疗计划设计时关注mCPD和胸椎骨髓受照 spared体积,可能有助于预测和减轻放化疗期间的白细胞减少。
- 对于女性、年龄<67岁或>67岁以及合并糖尿病的患者,治疗期间可加强血细胞计数监测。
局限性
- 本研究为单中心小样本(46例)回顾性分析,结果需更大样本验证。
- mCPD作为循环血池替代指标,TVS参数与骨髓功能的直接关联尚未明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Lymphopenia is associated with poor outcomes in esophageal cancer (EC) patients undergoing chemoradiotherapy (CRT). We hypothesized that radiation dose to marrow (central) vs. circulating (peripheral) leukocytes (WBCs) may have unique effects on WBC counts and clinical outcomes in EC. MATERIALS AND METHODS: Weekly and 90-day post-CRT blood cell counts were evaluated for 46 patients with stage II-III EC treated with CRT. Thoracic vertebral volume spared (TVS) radiation was extracted from dose volume histograms (DVH). Mean cardiopulmonary dose (mCPD) was calculated as mean dose to the volumetric sum of heart, lungs, and great vessels as a surrogate for circulating blood pool. Linear and logistic regression identified associations between dosimetric variables and hematologic toxicities (HT). Repeated measures ANOVA tested associations between cell count trends and clinical predictors. RESULTS: WBCs and platelets reached nadir at week 6 of CRT. On multivariate analysis, mCPD was associated with lower WBC and neutrophil nadirs (p < 0.05). TVS5-40 Gy were associated with higher lymphocyte nadirs (all p < 0.05). Repeated measures ANOVA revealed an interaction effect of sex on absolute lymphocyte trend as well as age (<67 vs. >67) and diabetes on normalized lymphocyte trend (all p < 0.015). CONCLUSIONS: mCPD and volume of thoracic marrow spared radiation differentially predict lineage-specific leukopenias during CRT for EC. mCPD is significantly associated with lower total WBC and neutrophil nadirs. In contrast, greater thoracic marrow spared radiation is associated with mitigation of lymphopenia during CRT. Clinical factors such as sex, age, and diabetes may be associated with a more rapid decline in hematologic counts during treatment.
引用
- Anderson JL, Newman NB, Anderson C, et al. Mean cardiopulmonary dose and vertebral marrow dose differentially predict lineage-specific leukopenia kinetics during radiotherapy for esophageal cancer. Radiother Oncol. 2020. PMID: 32291110. doi:10.1016/j.radonc.2019.12.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。